Sera Prognostics Statistics
NASDAQ: SERAHealth CareMedical SpecialitiesUSD
1.81-0.08 (-4.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Sera Prognostics by the numbers
Sera Prognostics has a market capitalization of $72.0 million based on 38.80M shares outstanding. With trailing EPS of $-0.67, Sera Prognostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.9% below its 50-day average and 11.7% below its 200-day average.
Average daily trading volume is 27.84K shares, or about $50,394 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SERA valuation vs. peer median
| Metric | SERA | Peer median | Difference |
|---|---|---|---|
| Market cap | $71.98M | $47.04M | +53% |
| Avg. volume | 27.84K | 62.45K | -55% |
Peer median across 8 companies: BDSX, XGN, KEQU, MDXH, AMS, BNR, ACON, ADVB.
Valuation
- Market cap
- $71.98M
- Price / sales (latest FY)
- 888.68
- EPS (TTM)
- $-0.67
- Shares outstanding
- 38.80M
Price and trading
- Previous close
- 1.89
- Open
- 1.82
- Day range
- 1.80 – 1.87
- 52-week range
- 1.56 – 3.85
- 52-week change
- -43.96%
- Beta
- —
- Volume
- 94.60K
- Average volume
- 27.84K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 71.98M
- Forward Pe
- -3.18
- Eps
- -0.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.85
- Week52 Low
- 1.56
- Avg Volume
- 27,842.00
- Shares Outstanding
- 38.80M
- Ma50
- 2.03
- Ma200
- 2.05
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -52.99%
- Pct From52w Low
- 16.03%